Use of estriol in the preparation of a pharmaceutical formulation parael treatment of vaginal atrophy in women at risk of potologiatumoral.

Use of estriol in the preparation of a pharmaceutical formulation for the treatment of vaginal atrophy in women at risk of tumor pathology. Use of estriol in the preparation of pharmaceutical formulations for vaginal administration for the prevention and / or treatment of urogenital atrophy due to estrogen deficiency such formulations characterized by their ability to self-limit the absorption of estriol being.